Notify me when Samir Rashmikant Patel files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | Ordinary Shares, $0.000000005 par value | 10% | $2,334,051,600 | 9,725,215,000 | Samir R. Patel | 02 Mar 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|